Trending

24/7 MN – (NASDAQ:ALDX) shares are up this morning on top line results from a clinical study, shares are at$5.11 this morning and poised to move up

Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from the Dry Eye Disease Chamber Crossover Clinical Trial of Reproxalap

https://www.businesswire.com/news/home/20220711005532/en/Aldeyra-Therapeutics-Schedules-Conference-Call-and-Webcast-to-Announce-Top-Line-Results-from-the-Dry-Eye-Disease-Chamber-Crossover-Clinical-Trial-of-Reproxalap

RelatedNews

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist